Farms.com Home   News

Manage Each Field for Its Own Conditions

Crop stage from crop to crop is highly variable, and is one of many reasons why neighbouring crops can’t be treated the same.

Canola crops side by side can have different risk factors, and often do not require the same crop management for nutrients, weeds, insects and disease. Crop rotation, fertilizer rates, plant population and stand uniformity are a few factors that can influence whether one crop needs a treatment while the other right beside may not.

Crop stage is another important factor. Cabbage seedpod weevil, for example, is attracted to the earliest flowering fields in an area. Therefore these early fields may be at control thresholds while later fields never have enough weevils to warrant a spray.

The key is to manage each crop according to its own needs. Decisions made for one field based on what is required (or not required) in the field next door may not be in the best interest of profitability — especially this year.

Source: Alberta Canola Producers Commission


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.